Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $13.3800 (-1.44%) ($13.3800 - $13.3800) on Tue. Sep. 20, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.08% (three month average) | RSI | 45 | Latest Price | $13.3800(-1.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.3% a day on average for past five trading days. | Weekly Trend | BCRX declines -2.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) VUG(33%) XLK(33%) URA(32%) VT(32%) BLOK(30%) | Factors Impacting BCRX price | BCRX will decline at least -2.04% in a week (0% probabilities). VIXM(-15%) UUP(-14%) SMH(-11%) VXX(-3%) EDOC(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.04% (StdDev 4.08%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $6.26(-53.21%) | Resistance Level | $13.77 | 5 Day Moving Average | $13.27(0.83%) | 10 Day Moving Average | $13.41(-0.22%) | 20 Day Moving Average | $13.77(-2.83%) | To recent high | -9.7% | To recent low | 41.9% | Market Cap | $2.361b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |